Antiviral Research

Article	Citations
RBD design increases the functional antibody titers elicited by SARS-CoV-2 spike vaccination	382
Editorial Board	117
Editorial Board	102
Editorial Board	86
Corrigendum to “Crystal structure and cap binding analysis of the methyltransferase of langat virus” [Antivir. Res. 208 (2022) 105459]	79
Editorial Board	68
Development of MDCK-based quadrivalent split seasonal influenza virus vaccine with high safety and immunoprotection: A preclinical study	60
Long-term and efficient inhibition of hepatitis B virus replication by AAV8-delivered artificial microRNAs	58
Assessment of the broad-spectrum host targeting antiviral efficacy of halofuginone hydrobromide in human airway, intestinal and brain organotypic models.	52
A novel model based on qAnti-HBc and conventional biomarkers for identifying significant liver injury among CHB patients with ALT ≤ ULN	47
Progress in novel delivery technologies to improve efficacy of therapeutic antibodies	42
A broad-spectrum nanobody targeting the C-terminus of the hepatitis B surface antigen for chronic hepatitis B infection therapy	41
Novel inhibitors of HSV-1 protease effective in vitro and in vivo	38
Co-delivery of Cas9 mRNA and guide RNAs edits hepatitis B virus episomal and integration DNA in mouse and tree shrew models	37
Inhibition of p38 signaling curtails the SARS-CoV-2 induced inflammatory response but retains the IFN-dependent antiviral defense of the lung epithelial barrier	37
Comparison of the effects of different potent adjuvants on enhancing the immunogenicity and cross-protection by influenza virus vaccination in young and aged mice	36
Structural and quantitative comparison of viral infection-associated N-glycans in plasma from humans, pigs, and chickens: Greater similarity between humans and chickens than pigs	35
Targeted inhibition of IGF2BP1 effectively suppresses HBV replication via an m6A-dependent manner	35
Corrigendum to “The novel therapeutic target and inhibitory effects of PF-429242 against Zika virus infection” [Antivir. Res. vol 192 (2021) 1–13/105121]	34
Discovery and development of INNA-051, a TLR2/6 agonist for the prevention of complications resulting from viral respiratory infections	33
Methyl rosmarinate is an allosteric inhibitor of SARS-CoV-2 3 CL protease as a potential candidate against SARS-cov-2 infection	33
Editorial Board	33
Long-term effects of peginterferon-based therapy versus nucleos(t)ide analogue monotherapy in non-cirrhotic HBeAg-positive chronic hepatitis B patients	32
Assessment of repurposed compounds against coronaviruses highlights the antiviral broad-spectrum activity of host-targeting iminosugars and confirms the activity of potent directly acting antivirals	32
Conserved use of the sodium/bile acid cotransporter (NTCP) as an entry receptor by hepatitis B virus and domestic cat hepadnavirus	32

The prophylactic and therapeutic efficacy of the broadly active antiviral ribonucleoside N-Hydroxycytidine (EIDD-1931) in a mouse model of lethal Ebola virus infection	32
Chemical-induced degradation of PreS2 mutant surface antigen via the induction of microautophagy	32
JNJ-7184, a respiratory syncytial virus inhibitor targeting the connector domain of the viral polymerase	30
Ligand-based design of peptide entry inhibitors targeting the endosomal receptor binding site of filoviruses	27
Berberine promotes K48-linked polyubiquitination of HNF4α, leading to the inhibition of HBV replication	26
Novel strategy for Poxviridae prevention: Thermostable combined subunit vaccine patch with intense immune response	26
Hydroxychloroquine and azithromycin used alone or combined are not effective against SARS-CoV-2 ex vivo and in a hamster model	26
A novel high-throughput single B-cell cloning platform for isolation and characterization of high-affinity and potent SARS-CoV-2 neutralizing antibodies	25
N-arylpyrimidinamine (NAPA) compounds are broadly acting inhibitors of human cytomegalovirus infection and spread	25
Does a detectable HCV RNA at the end of DAA therapy herald treatment failure?	24
Generation of a panel of mutants that are resistant to standard of care therapies in a clinically relevant strain of human cytomegalovirus for drug resistance profiling	24
Implications of the antiviral drug favipiravir on rabies immunoglobulin for post-exposure prophylaxis of rabies in mice model with category III-like exposures	24
Chelerythrine chloride inhibits Zika virus infection by targeting the viral NS4B protein	23
Development of a robust and convenient dual-reporter high-throughput screening assay for SARS-CoV-2 antiviral drug discovery	23
Nirmatrelvir exerts distinct antiviral potency against different human coronaviruses	23
Clinical and experimental evidence for transplacental vertical transmission of flaviviruses	22
Discovery of new antiviral agents through artificial intelligence: In vitro and in vivo results	22
Ensitrelvir treatment–emergent amino acid substitutions in SARS-CoV-2 3CLpro detected in the SCORPIO-SR phase 3 trial	22
Design, synthesis and biological evaluation of a novel series of conjugates of N1-(phosphonoalkyl)-1,2,3-triazoles and N3-benzyl-6-bromoquinazoline-2,4-diones with anti-RSV activity	22
High dose sofosbuvir and sofosbuvir-plus-ribavirin therapy inhibit Hepatitis E Virus (HEV) replication in a rabbit model for acute HEV infection	22
Therapeutic targeting of organelles for inhibition of Zika virus replication in neurons	22
Novel siRNA therapeutics demonstrate multi-variant efficacy against SARS-CoV-2	22
A mimetic peptide of ACE2 protects against SARS-CoV-2 infection and decreases pulmonary inflammation related to COVID-19	22
Numb-associated kinases are required for SARS-CoV-2 infection and are cellular targets for antiviral strategies	22
MβCD inhibits SFTSV entry by disrupting lipid raft structure of the host cells	22
Potent inhibition of diverse Omicron sublineages by SARS-CoV-2 fusion-inhibitory lipopeptides	21
Bictegravir alters glucose tolerance in vivo and causes hepatic mitochondrial dysfunction	21
Identification of novel Ebola virus inhibitors using biologically contained virus	21
Research Alliance for Veterinary Science and Biodefense BSL-3 Network (RAV3N): Report on network origin and phase I activities	21
Differential effects of antiretroviral HIV integrase inhibitors on vascular cell adhesion molecules	21
Characterization of remdesivir resistance mutations in COVID-19 patients with various immunosuppressive diseases	21
Establishment of a robust rat hepatitis E virus fecal-oral infection model and validation for antiviral studies	21
Inhibition of Chikungunya virus early replication by intracellular nanoantibodies targeting nsP2 Epitope Rich Region	21
Structural biology of flavivirus NS1 protein and its antibody complexes	21
Editorial Board	20
Editorial Board	20
Molecular mechanisms of hepatitis B virus entry inhibition by a bile acid derivative INT-767 binding to the preS1 region	20
Lung transcriptomics of K18-hACE2 mice highlights mechanisms and genes involved in the MVA-S vaccine-mediated immune response and protection against SARS-CoV-2 infection	20
Intranasal delivery of an adenovirus-vector vaccine co-expressing a modified spike protein and a genetic adjuvant confers lasting mucosal immunity against SARS-CoV-2	20
Comprehensive Herpesviruses Antiviral drug Resistance Mutation Database (CHARMD)	20
Host factor DUSP5 potently inhibits dengue virus infection by modulating cytoskeleton rearrangement	20
A spatiotemporally controlled recombinant cccDNA mouse model for studying HBV and developing drugs against the virus	20
LAVR-289, a broad-spectrum antiviral, protects immunosuppressed Syrian hamsters against lethal adenovirus challenge	19
Targeting the host transcription factor HSF1 prevents human cytomegalovirus replication in vitro and in vivo	19
Lipid-targeting antiviral strategies: Current state and future perspectives	19
Sulfated β-glucan from Agaricus subrufescens inhibits flavivirus infection and nonstructural protein 1-mediated pathogenesis	19
Performance of sofosbuvir and NITD008 in extrahepatic neuronal cells against HEV	19
Antiviral effect of vesatolimod (GS-9620) against foot-and-mouth disease virus both in vitro and in vivo	19
High throughput profiling identified PA-L106R amino acid substitution in A(H1N1)pdm09 influenza virus that confers reduced susceptibility to baloxavir in vitro	19
HIV protease inhibitor attenuated astrocyte autophagy involvement in inflammation via p38 MAPK pathway	19

Large-scale deep learning identifies the antiviral potential of PKI-179 and MTI-31 against coronaviruses	18
Eeyarestatin I, an inhibitor of the valosin-containing protein, exhibits potent virucidal activity against the flaviviruses	18
Nanomolar anti-SARS-CoV-2 Omicron activity of the host-directed TMPRSS2 inhibitor N-0385 and synergistic action with direct-acting antivirals	18
Broad-spectrum antiviral activity of two structurally analogous CYP3A inhibitors against pathogenic human coronaviruses in vitro	18
The diverse roles of peroxisomes in the interplay between viruses and mammalian cells	18
Intranasal exposure to commensal bacterium Rothia mucilaginosa protects against influenza A virus infection	18
Interim analysis of the PARADISE study: Benefits of add-on peginterferon-α in NA-treated patients with CHB	18
Editorial Board	17
Targeting PI4KB and Src/Abl host kinases as broad-spectrum antiviral strategy: Myth or real opportunity?	17
The protease inhibitor Nirmatrelvir synergizes with inhibitors of GRP78 to suppress SARS-CoV-2 replication	17
The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters	17
Virus infection and sphingolipid metabolism	17
Development of a rapid image-based high-content imaging screening assay to evaluate therapeutic antibodies against the monkeypox virus	17
Nucleotide analogues and mpox: Repurposing the repurposable	17
Biological characterization of AB-343, a novel and potent SARS-CoV-2 Mpro inhibitor with pan-coronavirus activity	17
Avasimibe can cooperate with a DC-targeting and integration-deficient lentivector to induce stronger HBV specific T cytotoxic response by regulating cholesterol metabolism	17
Antigenic mapping of enterovirus A71 from Taiwan and Southeast Asia	17
Flexible nano-liposomes-encapsulated recombinant UL8-siRNA (r/si-UL8) based on bioengineering strategy inhibits herpes simplex virus-1 infection	17
Induction of neutralizing antibodies and mucosal IgA through intranasal immunization with the receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxi	16
Porcine interferon-α linked to the porcine IgG-Fc induces prolonged and broad-spectrum antiviral effects against foot-and-mouth disease virus	16
Identification of alpha-linolenic acid as a broad-spectrum antiviral against zika, dengue, herpes simplex, influenza virus and SARS-CoV-2 infection	16
Structural and mechanistic insight into the phosphorylation reaction catalyzed by mpox virus thymidine kinase	16
Novel bispecific human antibody platform specifically targeting a fully open spike conformation potently neutralizes multiple SARS-CoV-2 variants	16
Hemin protects against Zika virus infection by disrupting virus-endosome fusion	16
Editorial Board	16
Design and synthesis of a new series of hybrids of functionalised N1-[(1H-1,2,3-triazol-4-yl)methyl]quinazoline-2,4-dione with antiviral activity against Respiratory Syncytial Virus	15
Editorial Board	15
Astersaponin I from Aster koraiensis is a natural viral fusion blocker that inhibits the infection of SARS-CoV-2 variants and syncytium formation	15
Targeting sgRNA N secondary structure as a way of inhibiting SARS-CoV-2 replication	15
RNA virus infections and their effect on host alternative splicing	15
Construction of a recombinant African swine fever virus with firefly luciferase and eGFP reporter genes and its application in high-throughput antiviral drug screening	15
The lack of HBsAg secretion does neither facilitate induction of antiviral T cell responses nor Hepatitis B Virus clearance in mice	15
Niclosamide inhibits hepatitis E virus through suppression of NF-kappaB signalling	15
Antiviral drug discovery with an optimized biochemical dengue protease assay: Improved predictive power for antiviral efficacy	15
New technologies in therapeutic antibody development: The next frontier for treating infectious diseases	14
Three in one: An effective and universal vaccine expressing heterologous tandem RBD trimer by rabies virus vector protects mice against SARS-CoV-2	14
Identification of West Nile virus RNA-dependent RNA polymerase non-nucleoside inhibitors by real-time high throughput fluorescence screening	14
Editorial Board	14
High-throughput drug screen identifies calcium and calmodulin inhibitors that reduce JCPyV infection	14
GS-1 blocks entry of herpes viruses and more broadly inhibits enveloped viruses	14
Development of a novel minigenome and recombinant VSV expressing Seoul hantavirus glycoprotein-based assays to identify anti-hantavirus therapeutics	14
Coronavirus nucleocapsid-based vaccine provides partial protection against hetero-species coronavirus in murine models	14
Activity of Sotrovimab against BQ.1.1 and XBB.1 Omicron sublineages in a hamster model	14
Editorial Board	14
CDK4/6 inhibitor palbociclib promotes SARS-CoV-2 cell entry by down-regulating SKP2 dependent ACE2 degradation	14
Editorial Board	14
The host-targeted antiviral drug Zapnometinib exhibits a high barrier to the development of SARS-CoV-2 resistance	14
Diketo acid inhibitors of nsp13 of SARS-CoV-2 block viral replication	14
History and impact of the mouse-adapted Ebola virus model	14
Retrospective analysis of steatosis effect on antiviral response and hepatocellular carcinoma risk in chronic hepatitis C	14
RNA-Binding motif protein 38 (RBM38) mediates HBV pgRNA packaging into the nucleocapsid	13
Isochlorogenic acid A impairs hepatitis B virus replication by interference with various steps of hepatitis B virus life cycle involving HO-1-mediated ROS modulation	13
Deubiquitinase USP39 promotes SARS-CoV-2 replication by deubiquitinating and stabilizing the envelope protein	13
Antiviral strategies against human metapneumovirus: Targeting the fusion protein	13
The combination of pleconaril, rupintrivir, and remdesivir efficiently inhibits enterovirus infections in vitro, delaying the development of drug-resistant virus variants	13
Cold-adapted influenza vaccine carrying three repeats of a respiratory syncytial virus (RSV) fusion glycoprotein epitope site protects BALB/c mice and cotton rats against RSV infection	13
Ciliatoside A, isolated from Peristrophe japonica, inhibits HBsAg expression and cccDNA transcription by inducing autophagy	13
Current and future use of antibody-based passive immunity to prevent or control HBV/HDV infections	13
Salicylamide derivative JMX0312 protects immunosuppressed Syrian hamsters against adenovirus lethal challenge	13
Screening and identification of Lassa virus endonuclease-targeting inhibitors from a fragment-based drug discovery library	13
25R,26-hydroxycholesterol and an oxysterol synthetic analog inhibit Varicella zoster Virus replication	12
PRO-2000 exhibits SARS-CoV-2 antiviral activity by interfering with spike-heparin binding	12
Optimization of Bangladesh and Malaysian genotype recombinant reporter Nipah viruses for in vitro antiviral screening and in vivo disease modeling	12
Influenza antivirals and their role in pandemic preparedness	12
Induction of antiviral gene expression by cyclosporine A, but not inhibition of cyclophilin A or B, contributes to its restriction of human coronavirus 229E infection in a lung epithelial cell line	12
Editorial Board	12
Investigating N-arylpyrimidinamine (NAPA) compounds as early-stage inhibitors against human cytomegalovirus	12
Evaluation of panel of neutralising murine monoclonal antibodies and a humanised bispecific antibody against influenza A(H1N1)pdm09 virus infection in a mouse model	12
JC polyomavirus-encoded miRNA jcv-miR-J1-5p downregulates BK polyomavirus infection	12
Editorial Board	12
Editorial Board	12
Identification of structurally re-engineered rocaglates as inhibitors against hepatitis E virus replication	12
Nafamostat mesylate as a broad-spectrum candidate for the treatment of flavivirus infections by targeting envelope proteins	12
Editorial Board	12
Exploiting host kinases to combat dengue virus infection and disease	11
The calcium channel inhibitor lacidipine inhibits Zika virus replication in neural progenitor cells	11
Editorial Board	11
Effect of antivirals on clinical and lab-adapted human cytomegalovirus strains using induced pluripotent stem cell-derived human neural models	11
Induction of a strong and long-lasting neutralizing immune response by dPreS1-TLR2 agonist nanovaccine against hepatitis B virus	11
Effect of E23G/K, F36V, N37T, E119D, and E199G polymerase acidic protein substitutions on the replication and baloxavir susceptibility of influenza B viruses	11

Expanding the anti-flaviviral arsenal: Discovery of a baicalein-derived Compound with potent activity against DENV and ZIKV.	11
Recombinant pseudorabies virus (PRV) expressing stabilized E2 of classical swine fever virus (CSFV) protects against both PRV and CSFV	11
A novel cellular tool for screening human pan-coronavirus antivirals	11
β-d-N4-hydroxycytidine, a metabolite of molnupiravir, exhibits in vitro antiviral activity against rabies virus	11
Dynamic features of virus protein 1 and substitutions in the 3-phenyl ring determine the potency and broad-spectrum activity of capsid-binding pyrazolo[3,4-d]pyrimidines against rhinoviruses	11
Tissue replication and mucosal swab detection of Sosuga virus in Syrian hamsters in the absence of overt tissue pathology and clinical disease	11
RBM24 inhibits the translation of SARS-CoV-2 polyproteins by targeting the 5ʹ-untranslated region	11
CD47 expression attenuates Ebola virus-induced immunopathology in mice	11
Ganciclovir and maribavir cross-resistance revisited: Relative drug susceptibilities of canonical cytomegalovirus mutants	11
Editorial Board	11
Antisense oligonucleotides as drugs with both direct and indirect antiviral actions	11
Drug repurposing platform for deciphering the druggable SARS-CoV-2 interactome	11
Evaluation of pharmacokinetics of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil (TDF) in pregnant and postpartum women in South Africa: PrEP-PP PK study	11
Insights on the antiviral mechanisms of action of the TLR1/2 agonist Pam3CSK4 in hepatitis B virus (HBV)-infected hepatocytes	11
Vemurafenib inhibits the replication of diabetogenic enteroviruses in intestinal epithelial and pancreatic beta cells	10
Mechanisms of action of repurposed Ebola virus antivirals – the roles of phospholipidosis and cholesterol homeostasis	10
Negative regulation of SREBP-1/FAS signaling molecules activates the RIG-1/TBK1-mediated IFN-I pathway to inhibit BVDV replication	10
Marburg and Kasokero viruses elicit differential antiviral innate immune control by their natural reservoir bat, the Egyptian rousette (Rousettus aegyptiacus)	10
β-D-N4-hydroxycytidine (NHC, EIDD-1931) inhibits chikungunya virus replication in mosquito cells and ex vivo Aedes aegypti guts, but not when ingested during blood-feeding	10
Activation of cGAS-STING suppresses coxsackievirus replication via interferon-dependent signaling	10
Cathepsin inhibitors nitroxoline and its derivatives inhibit SARS-CoV-2 infection	10
Cholesterol 25-hydroxylase inhibits Newcastle disease virus replication by its architectural damage and blocking HN protein	10
Antiviral mechanisms and preclinical evaluation of amantadine analogs that continue to inhibit influenza A viruses with M2S31N-based drug resistance	10
Small molecule direct-acting antivirals for treatment of mpox	10
Development and optimization of biologically contained Marburg virus for high-throughput antiviral screening	10
Screening of an epigenetic compound library identifies BRD4 as a potential antiviral target for hepatitis B virus covalently closed circular DNA transcription	10
Association of C-reactive protein polymorphisms with serum-CRP concentration and viral load among dengue-chikungunya mono/co-infected patients	10
Inhibitors of pyrimidine synthesis synergize with N4-hydroxycytidine to diminish influenza virus replication	10
Inhibitors of mpox VP39 2′-O methyltransferase efficiently inhibit the monkeypox virus	10
Functional assessments of SARS-CoV-2 single-round infectious particles with variant-specific spike proteins on infectivity, drug sensitivity, and antibody neutralization	10
Discovery of broad-spectrum antivirals targeting viral proteases using in silico structural modeling and cellular analysis	10
Targeting of the cellular ATM rather than ATR kinase exhibits therapeutic potential during the lumpy skin disease virus infection in vivo and in vitro	10
Generation and evaluation of protease inhibitor-resistant SARS-CoV-2 strains	10
Verteporfin is a broad-spectrum inhibitor of arboviruses and influences viral and host-based events	10
Editorial Board	9
5-(Perylen-3-ylethynyl)uracil as an antiviral scaffold: Potent suppression of enveloped virus reproduction by 3-methyl derivatives in vitro	9
Viral sequence analysis of chronic hepatitis B patients treated with the capsid assembly modulator JNJ-56136379 in the JADE phase 2a study	9
Anti-SARS-CoV-2 activity of cyanopeptolins produced by Nostoc edaphicum CCNP1411	9
Anti-SARS-CoV-2 gapmer antisense oligonucleotides targeting the main protease region of viral RNA	9
A potent neutralizing and protective antibody against a conserved continuous epitope on HSV glycoprotein D	9
Cyclic lipopeptides as membrane fusion inhibitors against SARS-CoV-2: New tricks for old dogs	9
Low antiviral resistance in Influenza A and B viruses isolated in Mexico from 2010 to 2023	9
Evaluation of a novel severe combined immunodeficiency mouse model for antiviral drug evaluation against Chandipura virus infection	9
Editorial Board	9
A screen of FDA-approved drugs with minigenome identified tigecycline as an antiviral targeting nucleoprotein of Crimean-Congo hemorrhagic fever virus	9
Characterization of SARS-CoV-2 replication in human H1299/ACE2 cells: A versatile and practical infection model for antiviral research and beyond	9
Antiviral drugs block replication of highly immune-evasive Omicron subvariants ex vivo, but fail to reduce tissue inflammation	9
Identification of critical residues in the regulatory protein HBx for Smc5/6 interaction and hepatitis B virus production	9
Mapping the impact of 1′-, 2′- and 4′-nucleotide modifications on the Respiratory Syncytial Virus RNA-dependent RNA polymerase	9
Editorial Board	9
Identification of pan-flavivirus compounds from drug repurposing	9
Identification of oxysterol synthetic analogs as a novel class of late-stage inhibitors of herpes simplex virus 2 replication	9
Punicalagin as an allosteric NSP13 helicase inhibitor potently suppresses SARS-CoV-2 replication in vitro	9
A bivalent form of a RBD-specific synthetic antibody effectively neutralizes SARS-CoV-2 variants	9
New insights into the neuraminidase-mediated hemagglutination activity of influenza A(H3N2) viruses	9
Influence of adjuvant type and route of administration on the immunogenicity of Leishmania-derived tick-borne encephalitis virus-like particles – A recombinant vaccine candidate	9
Characterization of clinical envelopes with lack of sensitivity to the HIV-1 inhibitors temsavir and ibalizumab	9
α7 nicotinic receptor activation mitigates herpes simplex virus type 1 infection in microglia cells	9
Bithiazole inhibitors of PI4KB show broad-spectrum antiviral activity against different viral families	9
Assessing the chronic hepatitis B adaptive immune response by profiling specific T-cell receptor repertoire	9
Pinostrobin from plants and propolis against human coronavirus HCoV-OC43 by modulating host AHR/CYP1A1 pathway and lipid metabolism	9
Antiviral activity of porphyrins and porphyrin-like compounds against tick-borne encephalitis virus: Blockage of the viral entry/fusion machinery by photosensitization-mediated destruction of the vira	9
The ApoA1-mimetic peptide 4F blocks flavivirus NS1-triggered endothelial dysfunction and protects against lethal dengue virus challenge	9
KDM5A/B contribute to HIV-1 latent infection and survival of HIV-1 infected cells	9
Flavivirus NS4B protein: Structure, function, and antiviral discovery	8
Seasonal coronavirus infections trigger NLRP3 inflammasome activation in macrophages but is therapeutically targetable	8
SARS-CoV-2 Omicron (B.1.1.529) shows minimal neurotropism in a double-humanized mouse model	8
Editorial Board	8
Structural characterization of HIV fusion inhibitor LP-98: Insights into antiviral and resistance mechanisms	8
A rapid and versatile reverse genetic approach and visualization animal models for emerging zoonotic pseudorabies virus	8
The conserved core nuclear egress complex (NEC) as an antiherpesviral drug target: Pharmacophore-based identification of NEC-specific inhibitors	8
ESCRT machinery and virus infection	8
Fangchinoline inhibits SARS-CoV-2 and MERS-CoV entry	8
Kill or corrupt: Mechanisms of action and drug-resistance of nucleotide analogues against SARS-CoV-2	8
Zika virus replication is impaired by a selective agonist of the TRPML2 ion channel	8
The antiviral effects of a MEK1/2 inhibitor promote tumor regression in a preclinical model of human papillomavirus infection-induced tumorigenesis	8
Apatinib inhibits HTNV by stimulating TFEB-driven lysosome biogenesis to degrade viral protein	8
SARS-CoV-2 virus-like particle variants alpha and delta mimic the native viruses in their differential inflammasome activating potential	8
TLR2-mediated mucosal immune priming boosts anti-rhabdoviral immunity in early vertebrates	8
Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2	8
Treatment efficacy of cidofovir and brincidofovir against clade II Monkeypox virus isolates	8
Antiviral activity of the HSP90 inhibitor VER-50589 against enterovirus 71	8
Editorial Board	8
SARS-CoV-2 Resistance Analyses From the Phase 3 OAKTREE Study of Obeldesivir in Low-Risk Nonhospitalized Participants With COVID-19	8
ML390 inhibits enterovirus 71 replication by targeting de novo pyrimidine biosynthesis pathway	8
Design, synthesis, and biological evaluation of novel 2′-deoxy-2′-spirooxetane-7-deazapurine nucleoside analogs as anti-SARS-CoV-2 agents	8
HIV protease inhibitors Nelfinavir and Lopinavir/Ritonavir markedly improve lung pathology in SARS-CoV-2-infected Syrian hamsters despite lack of an antiviral effect	8
Thermodynamic and structural characterization of an optimized peptide-based inhibitor of the influenza polymerase PA-PB1 subunit interaction	8
Very low levels of remdesivir resistance in SARS-COV-2 genomes after 18 months of massive usage during the COVID19 pandemic: A GISAID exploratory analysis	8
Biology of hepatitis B virus DNA integration and its impact on antiviral R&D	8
A circular mRNA vaccine prototype producing VFLIP-X spike confers a broad neutralization of SARS-CoV-2 variants by mouse sera	8
The efficiency of high-throughput screening (HTS) and in-silico data analysis during medical emergencies: Identification of effective antiviral 3CLpro inhibitors	8
Recombinant porcine interferon cocktail delays the onset and lessens the severity of African swine fever	8
Identifying hypaphorine as a novel antiviral compound against dengue virus	8
Mechanism of interferon alpha therapy for chronic hepatitis B and potential approaches to improve its therapeutic efficacy	8